tenace burro scusa mog multiple sclerosis Misericordioso Samuel Di chi
Myelin oligodendrocyte glycoprotein revisited—sensitive detection of MOG-specific T-cells in multiple sclerosis - ScienceDirect
MOG-IgG associated optic neuritis is not multiple sclerosis - Arquivos de Neuro-Psiquiatria
EAE: imperfect but useful models of multiple sclerosis: Trends in Molecular Medicine
Multiple Sclerosis | NEJM
MS VS NMOSD VS MOGAD-CBC/DP SERIES - YouTube
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy: Trends in Molecular Medicine
Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care - The Lancet Neurology
Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis - ScienceDirect
Frontiers | MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease
MOG-IgG in Multiple Sclerosis - YouTube
Brain Sciences | Free Full-Text | Advances in Multiple Sclerosis Research–Series I
The spectrum of MOG autoantibody-associated demyelinating diseases | Nature Reviews Neurology
Myelin-oligodendrocyte glycoprotein antibody-associated disease - The Lancet Neurology
ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports | Neurology Neuroimmunology & Neuroinflammation
Serum level of IL-1β in patients with inflammatory demyelinating disease: Marked upregulation in the early acute phase of MOG antibody associated disease (MOGAD) - ScienceDirect
Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis | Neurology Neuroimmunology & Neuroinflammation
Overview of patient cohort, antibody status, and anti-MOG antibody... | Download Scientific Diagram
Frontiers | Advantages and limitations of experimental autoimmune encephalomyelitis in breaking down the role of the gut microbiome in multiple sclerosis
Effect of Rapamycin on MOG-Reactive Immune Cells and Lipopolysaccharide-Activated Microglia: An In Vitro Approach for Screening New Therapies for Multiple Sclerosis | Journal of Interferon & Cytokine Research
Multiple sclerosis: experimental models and reality | SpringerLink